# Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

> **NCT01120132** · PHASE2 · COMPLETED · sponsor: **Fovea Pharmaceuticals SA** · enrollment: 716 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** CsA high dose
- **DRUG:** CsA low dose
- **DRUG:** PA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01120132
- **Lead sponsor:** Fovea Pharmaceuticals SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 716 (ACTUAL)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120132, "Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01120132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*